Catalyst Pharmaceuticals (NASDAQ: CPRX)
Catalyst Pharmaceuticals Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
Catalyst Pharmaceuticals Company Info
Catalyst Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in developing and commercializing novel medicines for patients living with rare diseases including Lambert-Eaton myasthenic syndrome, congenital myasthenic syndromes, MuSK antibody positive myasthenia gravis, spinal muscular atrophy type 3, and infantile spasms. The company was founded by Huckel E. Hubert and Patrick J. McEnany in January 2002 and is headquartered in Coral Gables, FL.
News & Analysis
3 Biotech Stocks You Can Buy and Hold for the Next Decade
These companies are still in the early innings of their growth potential.
Forget Shiba Inu: This Stock is Poised for a Potential Bull Run in 2024
With multiple drugs on the market and revenue ramping up, the sky's the limit.
2 Robinhood Stocks With Market-Beating Potential
These diamonds in the rough won't stay down.
Down 19% in 1 Day, Is Catalyst Pharmaceuticals a Smart Contrarian Buy?
When evaluating investments, it helps to keep quarterly performance in context.
2 Top Growth Stocks That Can Withstand an Economic Downturn
These two drugmakers should march higher in 2023 and beyond.
1 Growth Stock to Buy Before the Next Bull Market
The stock is on a roll, and the company just made a major new purchase.
2 Growth Stocks to Invest $1,000 in Right Now
Both of these biopharmas have major catalysts that are in play or drawing near.
2 Breakout Growth Stocks to Buy for the Long Haul
These two stocks are entirely different, but they both make shareholders richer.
Valuation
Earnings Transcripts
Catalyst Pharmaceuticals, inc (CPRX) Q3 2021 Earnings Call Transcript
CPRX earnings call for the period ending September 30, 2021.
Catalyst Pharmaceuticals, inc (CPRX) Q2 2021 Earnings Call Transcript
CPRX earnings call for the period ending June 30, 2021.
Catalyst Pharmaceuticals Inc (CPRX) Q1 2021 Earnings Call Transcript
CPRX earnings call for the period ending March 31, 2021.
Catalyst Pharmaceuticals Inc (CPRX) Q3 2020 Earnings Call Transcript
CPRX earnings call for the period ending September 30, 2020.
Related Stocks
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.